Publication Details

Surgical outcomes and complications associated with presurgical tyrosine kinase inhibition for advanced renal cell carcinoma (RCC).

Harshman LC, Yu RJ, Allen GI, Srinivas S, Gill HS, Chung BI. Urol Oncol. 2013; 31 (3): 379-85

Tyrosine kinase inhibitors (TKI) have dramatically changed the management paradigm of advanced renal cell carcinoma (RCC) and are increasingly being used preoperatively to achieve cytoreduction.

PubMedID: 21353796